1. Home
  2. CGEM vs BH Comparison

CGEM vs BH Comparison

Compare CGEM & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • BH
  • Stock Information
  • Founded
  • CGEM 2016
  • BH 1934
  • Country
  • CGEM United States
  • BH United States
  • Employees
  • CGEM N/A
  • BH N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • BH Restaurants
  • Sector
  • CGEM Health Care
  • BH Consumer Discretionary
  • Exchange
  • CGEM Nasdaq
  • BH Nasdaq
  • Market Cap
  • CGEM 730.2M
  • BH 712.7M
  • IPO Year
  • CGEM 2021
  • BH N/A
  • Fundamental
  • Price
  • CGEM $11.87
  • BH $254.63
  • Analyst Decision
  • CGEM Strong Buy
  • BH
  • Analyst Count
  • CGEM 7
  • BH 0
  • Target Price
  • CGEM $31.67
  • BH N/A
  • AVG Volume (30 Days)
  • CGEM 514.5K
  • BH 14.7K
  • Earning Date
  • CGEM 11-07-2024
  • BH 11-08-2024
  • Dividend Yield
  • CGEM N/A
  • BH N/A
  • EPS Growth
  • CGEM N/A
  • BH 158.68
  • EPS
  • CGEM N/A
  • BH 180.85
  • Revenue
  • CGEM N/A
  • BH $361,664,000.00
  • Revenue This Year
  • CGEM N/A
  • BH N/A
  • Revenue Next Year
  • CGEM N/A
  • BH N/A
  • P/E Ratio
  • CGEM N/A
  • BH $15.39
  • Revenue Growth
  • CGEM N/A
  • BH N/A
  • 52 Week Low
  • CGEM $9.24
  • BH $145.95
  • 52 Week High
  • CGEM $30.19
  • BH $265.73
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 41.20
  • BH 69.14
  • Support Level
  • CGEM $10.44
  • BH $232.34
  • Resistance Level
  • CGEM $12.79
  • BH $265.73
  • Average True Range (ATR)
  • CGEM 0.67
  • BH 14.76
  • MACD
  • CGEM 0.03
  • BH 1.00
  • Stochastic Oscillator
  • CGEM 45.25
  • BH 75.98

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations, and Maxim. The majority of revenue is derived from the Restaurant Operations segment. The Restaurant Operations segment includes Steak n Shake and Western Sizzlin Restaurant businesses.

Share on Social Networks: